Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
MDxHealth SA - Ordinary Shares (MDXH)
Company Research
Source: GlobeNewswire
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42%2023 gross margin expanded by 10.7 percentage points over prior yearConference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – March 6, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the fourth quarter and year ended December 31, 2023. Michael K. McGarrity, CEO of mdxhealth, commented: “Our fourth quarter and full year 2023 results reflect our continued commitment to commercial execution and operational discipline that has driven significant gross margin expansion across our business. With each passing quarter, we continue to build on our position as a leading precision diagnostics company rooted in our industry-leading technology, focus on the highest quality customer experience,
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDXH
News
- Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering [Yahoo! Finance]Yahoo! Finance
- Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingGlobeNewswire
- MDxHealth SA (NASDAQ: MDXH) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
MDXH
Sec Filings
- 3/12/24 - Form 6-K
- 3/6/24 - Form 6-K
- 2/16/24 - Form 6-K
- MDXH's page on the SEC website